

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.45%
+0.91%
+4.04%
+0.96%
-2.22%
VTRS
Viatris
$10.31
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Chart
$9.52 (+8.30%)
$8.97 (+14.94%)
$8.72 (+18.23%)
$11.61 (-11.20%)
VTRS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

VTRS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
VTRS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VTRS Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayVTRS Earnings
The TTM reflects 12-month period, providing review of VTRS financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
TBPH
14.14
+1.00%
PFE
24.67
-0.22%
NVS
131.64
+0.15%
INDV
25.28
+1.53%
PRFX
1.26
+4.13%
What is VTRS current stock price?
What are VTRS stock strengths?
What risks are associated with VTRS stock?
When is VTRS next earnings report?
What is VTRS market cap and volume?
What is VTRS's current Stock IQ?
Should I buy VTRS stock right now?
Is VTRS a Strong Buy right now?
What does a 'Strong Buy' rating mean for VTRS?
What does a 'Strong Sell' rating mean for VTRS?
What factors influence VTRS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.45%
+0.91%
+4.04%
+0.96%
-2.22%
VTRS
Viatris
Current Price
$10.31
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Linked to VTRS
TBPH
14.14
+1.00%
PFE
24.67
-0.22%
NVS
131.64
+0.15%
INDV
25.28
+1.53%
PRFX
1.26
+4.13%
Chart
$9.52 (+8.30%)
$8.97 (+14.94%)
$8.72 (+18.23%)
$11.61 (-11.20%)
VTRS Analysts Opinion
VTRS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
VTRS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VTRS Street view is extremely bullish and have positive views on the near-term outlook
VTRS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
VTRS Earnings
The TTM data reflects the most recent 12-month period, providing overview of VTRS financial performance.
VTRS Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
VTRS Latest Analysis
Will Viatris (VTRS) Beat Estimates Again in Its Next Earnings Report?. Viatris (VTRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Tue Oct 21, 2025
Viatris Inc. (VTRS) Acquires Aculys Pharma Inc. Viatris Inc. (NASDAQ:VTRS) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 15 Viatris Inc. (NASDAQ:VTRS) announced completing the acquisition of Aculys Pharma Inc. which is a clinical-stage biopharmaceutical company. Aculys Pharma Inc. is commercializing innovative treatments for neurological conditions. Management noted that as a result of this acquisition [….]
Tue Oct 21, 2025
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan. VTRS acquires Aculys Pharma to boost its CNS portfolio in Japan gaining rights to pitolisant and Spydia for narcolepsy and seizure management respectively.
Thu Oct 16, 2025
Viatris completes Aculys Pharma acquisition.
Wed Oct 15, 2025
Truist Securities Initiates Coverage of Viatris (VTRS) with Buy Recommendation. Fintel reports that on October 15 2025 Truist Securities initiated coverage of Viatris (NasdaqGS:VTRS) with a Buy recommendation. Analyst Price Forecast Suggests 13.35% Upside
Wed Oct 15, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VTRS Stock trends
VTRS Stock performance
VTRS Stock analysis
VTRS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.